Evidence map›Paper›PMID 34497614›Full record

ArticleFrontiers in immunology2021

Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival.

Markus Wahrmann, Bernd Döhler, Marie-Luise Arnold, Sabine Scherer, Katharina A Mayer, Susanne Haindl, Helmuth Haslacher, Georg A Böhmig, Caner Süsal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants.Transplant international : official journal of the European Society for Organ Transplantation · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Markus WahrmannDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Bernd DöhlerInstitute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Marie-Luise ArnoldDepartment of Internal Medicine 3, Institute for Clinical Immunology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Sabine SchererInstitute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Katharina A MayerDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Susanne HaindlDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Helmuth HaslacherDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Georg A BöhmigDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Caner SüsalInstitute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Medical University of Vienna · ATUniversity Hospital Heidelberg · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The functional Fc gamma receptor (FcγR) IIIA polymorphism

Indexed as

GenotypeAdultAllograftsFemaleGraft RejectionHumansIsoantibodiesKidney TransplantationMaleMiddle AgedPolymorphism, Single NucleotideReceptors, IgGRetrospective StudiesSurvival AnalysisFCGR2A protein, humanFCGR3A protein, humanIsoantibodiesReceptors, IgGallograft survivalantibody-mediated rejectionanti-HLA antibodiesFc gamma receptorkidney transplantation

Identifiers

PMID34497614
PMCPMC8420807
OpenAlexW3195813321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.